Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Vanda Wins Rare US FDA Hearing As Years-Long Saga For Hetlioz Jet Lag Indication Continues
Mar 12 2026
•
By
Sue Sutter
Vanda will get a public hearing on a jet lag indication for Hetlioz.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Product Reviews
More from Pink Sheet